SCHEMBL7609032

SCHEMBL7609032

Cc1ccc(-c2ccc(CNC(=O)c3cccc(NC(=O)c4ccccc4-c4ccccc4)c3C)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 3/20 0.60
▸ CHRNA4 P43681 3/20 0.60
▸ CHRNB4 P30926 2/20 0.60
▸ CHRNA3 P32297 2/20 0.60
▸ ALDH1A1 P00352 4/20 0.51
▸ KDM4E B2RXH2 3/20 0.51
▸ HPGD P15428 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ KMT2A Q03164 3/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ PPARG P37231 3/20 0.49
▸ LMNA P02545 2/20 0.48
▸ TP53 P04637 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ HTT P42858 3/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ SUCNR1 Q9BXA5 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7610512 0.81 L3MBTL1 (0.61) CHRNB2CHRNA4CHRNB4CHRNA3ALDH1A1
SCHEMBL8614650 0.80 KMT2A (0.58) CHRNB2CHRNA4CHRNB4CHRNA3ALDH1A1
SCHEMBL7616965 0.78 HDAC8 (0.57) CHRNB2CHRNA4CHRNB4CHRNA3ALDH1A1
SCHEMBL8816842 0.77 KMT2A (0.52) CHRNB2CHRNA4CHRNB4CHRNA3ALDH1A1
SCHEMBL7605010 0.77 CHRNB2 (0.61) CHRNB2CHRNA4CHRNB4CHRNA3ALDH1A1
SCHEMBL8816782 0.77 CHRNB2 (0.54) CHRNB2CHRNA4CHRNB4CHRNA3ALDH1A1
SCHEMBL448354 0.77 HDAC2 (0.67) —
SCHEMBL7039230 0.76 CHRNB2 (0.51) CHRNB2CHRNA4CHRNB4CHRNA3ALDH1A1
SCHEMBL16802540 0.76 HPGD (0.58) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL7605854 0.76 L3MBTL1 (0.57) CHRNB2CHRNA4CHRNB4CHRNA3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments MTTP, CETP, FABP1 CHRNB2 4877/4885CHRNA4 4860/4885CHRNB4 4881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback